2017 Pediatric Rx, Module 3- Psychotropic Medications
Introduction:
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 0.75 NAPNAP contact hours, of which 0.75 is pharmacology and 0.75 related to psychopharmacology .
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org
Copyright 2017 © by National Association of Pediatric Nurse Practitioners (NAPNAP)
Target Audience
Pediatric-focused advanced practice registered nurses
Learning Objectives
- Participants will comprehend the basic mechanism of action of commonly used antidepressants and atypical antipsychotics
- Understand pharmacogenetic influences observed in response to and adverse effects associated with commonly prescribed psychotropic medications.
- Will be familiar with issues around managing or co-managing children and adolescents on antidepressants and atypical antipsychotics.
Teri Moser Woo, PhD, CPNP-BC, CNL, FAANP: Associate Dean for Graduate Nursing Programs, Pacific Lutheran University; PNP, Pediatric Urgent Care for Woodcreek Pediatrics, Puyallup, Wash.
FACULTY DISCLOSURES
Dr. Woo has no relevant financial relationships to disclose.
Available Credit
- 0.75 Contact hours